Breast Cancer
US Focus Meeting 2026
📍 Sheraton Grand Nashville Downtown, 623 Union St, Nashville, TN 37219
🗓️ April 24 - 25, 2026
Last Year's Highlights
Dear Colleagues and Friends,
We are delighted to extend our warmest invitation to the Breast Cancer Focus Meeting 2026, to be held on April 24 - 25, 2026.
Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing Breast Cancer research and patient treatment.
This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.
Chairs of Breast Cancer US Focus Meeting 2026:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
Virginia Kaklamani, MD
UT Health, San Antonio, TX
Thanks to our Supporters
Platinum
Gold
Additional support from Celcuity
Agenda & Faculty
April 24, 2026 | Day 1
10:00 AM
Registration Opens
Session I: Advances in HER2-Positive Breast Cancer
Moderated by:
Virginia Kaklamani, MD
UT Health, San Antonio, TX
11:05 AM
Defining the New Standard of Care for HER2-Positive Metastatic Breast Cancer
Abirami Sivapiragasam, MD
MUSC Health, Charleston, SC
11:25 AM
Optimizing Treatment of Early-Stage HER2-Positive Breast Cancer
Ian Krop, MD
Yale School of Medicine, New Haven, CT
11:45 AM
Management of Brain Metastases in Metastatic Breast Cancer
Andrew Brenner, MD
UT Health, San Antonio, TX
12:05 PM
12:25 PM
Panel Discussion
Coffee Break
Session II: Advances in Hormone Receptor-Positive Breast Cancer
Moderated by:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
12:45 PM
Novel Endocrine Therapies
Sarah Sammons, MD
Dana-Farber Cancer Institute, Boston, MA
01:05 PM
(Neo)Adjuvant Therapy for ER-Positive Breast Cancer
Cynthia Ma, MD
Washington University School of Medicine,
St. Louis, MO
01:25 PM
Novel Targeted Agents for ER+ Metastatic Breast Cancer
Seth Wander, MD
Massachusetts General Hospital Cancer Center, Boston, MA
01:45 PM
02:05 PM
Panel Discussion
Lunch Break + Faculty and Fellow Photo
Session III: Optimizing Treatment of Triple-Negative Breast Cancer
Moderated by:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
02:55 PM
Defining the New Standard of Care for Metastatic TNBC
Neil Iyengar, MD
Emory Winship Cancer Institute, Atlanta, GA
03:15 PM
Optimizing Treatment for Early-Stage TNBC
Yara Abdou, MD
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
03:35 PM
03:55 PM
Panel Discussion
Coffee Break
Session IV: Innovations in Breast Surgery
Moderated by:
Virginia Kaklamani, MD
UT Health, San Antonio, TX
04:15 PM
Endoscopic Breast Surgery: Is It the Future?
Hong Hu, MD
Shenzhen People’s Hospital, Guangdong
Province, China
04:35 PM
Optimizing Axillary Management for ER+ Breast Cancer: Is Less More?
Alastair Thompson, MD
Baylor College of Medicine, Houston, TX
04:55 PM
05:15 PM
Panel Discussion
Adjourn
Saturday, April 25, 2026 | Day 2
08:30 AM
Registration Opens
Session V: Challenging Metastatic Disease Scenarios
Moderated by:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
09:05 AM
The Future of Immunotherapy
Wassim Mchayleh, MD
Advent Health Cancer Institute, Orlando, FL
09:25 AM
Can We Cure Oligometastatic Disease?
Pavani Chalasani, MD
The George Washington University,
Washington, DC
09:45 AM
Treatment of Leptomeningeal Disease
Andrew Brenner, MD
UT Health, San Antonio, TX
10:05 AM
Treating for Molecular Progression
Lajos Pusztai, MD
Yale School of Medicine, New Haven, CT
10:25 AM
10:45 AM
Panel Discussion
Coffee Break
Session VI: Emerging Therapeutics and Special Perspectives
Moderated by:
Virginia Kaklamani, MD
UT Health, San Antonio, TX
11:05 AM
ADCs: Present and Future for “HER2- Negative” Breast Cancer
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center New York, NY
11:25 AM
Role of Radioligand Imaging and Therapy in Breast Cancer
Gary Ulaner, MD
Hoag Family Cancer Institute, Irvine, CA
11:45 AM
Lobular Breast Cancers: Should We Treat Them Distinctly?
Sherry Shen, MD
Memorial Sloan Kettering Cancer Center, New York, NY
12:05 PM
Best of SABCS (Radiation)
Richard Zellars, MD
Indiana University School of Medicine,
Indianapolis, IN
12:25 PM
12:45 PM
Panel Discussion
Lunch Break
Session VII: Breast Cancer Prevention and Risk Management
Moderated by:
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
01:35 PM
Updates on Breast Cancer Prevention
Virginia Kaklamani, MD
UT Health, San Antonio, TX
01:55 PM
Management of Genetically High-Risk Patients
Mark Robson, MD
Memorial Sloan Kettering Cancer Center, New York, NY
02:15 PM
Role of Exercise and GLP-1 Agonists in Breast Cancer
Saba Shaikh, MD
UT Health, San Antonio, TX
02:35 PM
02:55 PM
Panel Discussion
Coffee Break
Session VIII: Survivorship, Toxicity Management, and Patient
Moderated by:
Virginia Kaklamani, MD
UT Health, San Antonio, TX
03:15 PM
Oncofertility
Kate Lathrop, MD
UT Health, San Antonio, TX
03:35 PM
irAEs and Their Management
Shipra Gandhi, MD
Emory Winship Cancer Institute, Atlanta, GA
03:55 PM
Beyond Survival: Optimizing Endpoints in Contemporary Cancer Trials
Yu Shyr, MD
Vanderbilt University Medical Center,
Nashville, TN
04:15 PM
04:35 PM
Panel Discussion
Adjourn
Cristina Anton
Senior Project Manager
How long has Cristina Anton been in the business?
Cristina Anton has been with MD Education since 2022.
About Cristina Anton
As a Senior Project Manager at MD Education’s Wigan office since 2022, I organise international medical conferences with a focus on breast cancer and inflammatory bowel disease (IBD). Originally from Romania, I have been based in the UK since 2015. My diverse background across sectors helps me deliver high-quality, impactful educational programs. I’m committed to excellence and continuous growth.
